European Journal of Hematology
Fecha de publicación: 23 July 2019
Autores: Xiang Zhou, Patrick Wuchter, Gerlinde Egerer, Mark Kriegsmann, Aiste Mataityte, Christian Koelsche, Mathias Witzens‐Harig, Katharina Kriegsmann.
Background: Causality between hepatitis B virus (HBV) infection and diffuse large B‐cell lymphoma (DLBCL) was reported in various studies. However, the implication of different virological serum markers of HBV infection in patients with both HBV infection and DLBCL is not fully understood. The aim of this study was to investigate the impact of HBV markers on overall survival (OS) and progression‐free survival (PFS) in patients with both HBV infection and DLBCL.Leer más